CRISPR & Cas Genes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global CRISPR & Cas Genes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market Market Segment by Type, the product can be split into
Vector-based Cas
DNA-free Cas
Cell Line Engineering
Market Market Segment by Application, split into
Biotechnology and Pharmaceutical Companies
Academics and Government Research Institutes
Contract Research Organizations (CROs)
Based on regional and country-level analysis, the CRISPR & Cas Genes market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global CRISPR & Cas Genes market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
CRISPR Therapeutics
AstraZeneca
Addgene
Caribou Biosciences, Inc.
Cellectis
Editas Medicine, Inc.
Egenesis
F. Hoffmann-La Roche Ltd.
Horizon Discovery Group Plc
Genscrip
Danaher Corporation
Intellia Therapeutics, Inc.
Lonza
Merck KGaA
New England BioLabs
Takara Bio, Inc.
Synthego
Mammoth Biosciences
Inscripta, Inc.
Table of Contents
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2 Porter's Five Force Analysis
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
5. Global CRISPR Cas Genes Market, By Type
5.1 Introduction
5.2 Vector-based Cas, DNA-free Cas, Cell Line Engineering
5.2.1 Market Overview
5.2.2 Market Size and Forecast
6. Global CRISPR Cas Genes Market, By Application
6.1 Introduction
6.2 Biotechnology and Pharmaceutical Companies, Academics and Government Research Institutes, Contract Research Organizations (CROs)
6.2.1 Market Overview
6.2.2 Market Size and Forecast
7. Global CRISPR Cas Genes Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America CRISPR Cas Genes Market, By Type
7.2.2 North America CRISPR Cas Genes Market, By Application
7.3 Europe
7.3.1 Europe CRISPR Cas Genes Market, By Type
7.3.2 Europe CRISPR Cas Genes Market, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific CRISPR Cas Genes Market, By Type
7.4.2 Asia-Pacific CRISPR Cas Genes Market, By Application
7.5 Rest of the World
7.5.1 Rest of the World CRISPR Cas Genes Market Drugs, By Type
7.5.2 Rest of the World CRISPR Cas Genes Market, By Application
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 CRISPR Therapeutics, AstraZeneca, Addgene, Caribou Biosciences, Inc., Cellectis, Editas Medicine, Inc., Egenesis, F. Hoffmann-La Roche Ltd., Horizon Discovery Group Plc, Genscrip, Danaher Corporation, Intellia Therapeutics, Inc., Lonza, Merck KGaA, New England BioLabs, Takara Bio, Inc., Synthego, Mammoth Biosciences, Inscripta, Inc., Cibus
TABLE 1 CRISPR Cas Genes Market KEY MARKET SEGMENTS IN THIS STUDY 16
TABLE 2 KEY MANUFACTURERS CRISPR Cas Genes Market COVERED IN THIS STUDY 16
TABLE 3 GLOBAL CRISPR Cas Genes Market MARKET SIZE GROWTH RATE BY TYPE (2018-2025) (MILLION UNITS) & (MILLION US$) 17
TABLE 4 GLOBAL CRISPR Cas Genes Market MARKET SIZE GROWTH RATE BY APPLICATION (2018-2025) (MILLION UNITS) 20
TABLE 5 GLOBAL CRISPR Cas Genes Market CONSUMPTION MARKET SHARE BY APPLICATION IN 2017 20
TABLE 6 GLOBAL CRISPR Cas Genes Market MARKET SIZE GROWTH RATE BY REGIONS 2018-2025(MILLION UNITS) & (MILLION USD) 24
TABLE 7 GLOBAL MANUFACTURERS MARKET CONCENTRATION RATIO (CR5 AND HHI) 24
TABLE 8 CRISPR Cas Genes Market MANUFACTURING BASE DISTRIBUTION AND HEADQUARTERS) 25
TABLE 9 MANUFACTURERS CRISPR Cas Genes Market PRODUCT OFFERED 25
TABLE 10 DATE OF MANUFACTURERS ENTER INTO CRISPR Cas Genes Market MARKET 26
TABLE 11 KEY TRENDS FOR CRISPR Cas Genes Market MARKETS & PRODUCTS 26
TABLE 12 GLOBAL CRISPR Cas Genes Market PRODUCTION BY MANUFACTURERS (2013-2018) (MILLION UNITS) 27
TABLE 13 GLOBAL CRISPR Cas Genes Market PRODUCTION SHARE BY MANUFACTURERS (2013-2018) 27
TABLE 14 CRISPR Cas Genes Market REVENUE BY MANUFACTURERS (2013-2018) (MILLION USD) 28
TABLE 15 CRISPR Cas Genes Market REVENUE SHARE BY MANUFACTURERS (2013-2018) 29
TABLE 16 MERGERS & ACQUISITIONS, EXPANSION PLANS 29
TABLE 17 GLOBAL CRISPR Cas Genes Market PRODUCTION BY REGIONS 2013-2018 (MILLION UNITS) 30
TABLE 18 GLOBAL CRISPR Cas Genes Market PRODUCTION MARKET SHARE BY REGIONS 2013-2018 30
TABLE 19 GLOBAL CRISPR Cas Genes Market REVENUE BY REGIONS 2013-2018 (MILLION USD) 32
TABLE 20 GLOBAL CRISPR Cas Genes Market REVENUE MARKET SHARE BY REGIONS 2013-2018 32
TABLE 21 UNITED STATES CRISPR Cas Genes Market IMPORT & EXPORT (MILLION UNITS) 35
TABLE 22 EUROPE CRISPR Cas Genes Market IMPORT & EXPORT 37
TABLE 23 CHINA CRISPR Cas Genes Market IMPORT & EXPORT 39
TABLE 24 JAPAN CRISPR Cas Genes Market IMPORT & EXPORT 41
TABLE 25 SOUTH KOREA CRISPR Cas Genes Market IMPORT & EXPORT 43
TABLE 26 GLOBAL CRISPR Cas Genes Market CONSUMPTION BY REGIONS 2013-2018 (MILLION UNITS) 44
TABLE 27 GLOBAL CRISPR Cas Genes Market CONSUMPTION MARKET SHARE BY REGION 2013-2018 44
TABLE 28 UNITED STATES CRISPR Cas Genes Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 46
TABLE 29 UNITED STATES CRISPR Cas Genes Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 47
TABLE 30 EUROPE CRISPR Cas Genes Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 49
TABLE 31 EUROPE CRISPR Cas Genes Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 49
TABLE 32 CHINA CRISPR Cas Genes Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 51
TABLE 33 CHINA CRISPR Cas Genes Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 51
TABLE 34 JAPAN CRISPR Cas Genes Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 53
TABLE 35 JAPAN CRISPR Cas Genes Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 53
TABLE 36 SOUTH KOREA CRISPR Cas Genes Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 55
TABLE 39 SOUTH KOREA CRISPR Cas Genes Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 55
TABLE 40 GLOBAL CRISPR Cas Genes Market PRODUCTION BY TYPE (2013-2018) (MILLION UNITS) 57
TABLE 41 GLOBAL CRISPR Cas Genes Market PRODUCTION SHARE BY TYPE (2013-2018) 57
TABLE 42 GLOBAL CRISPR Cas Genes Market REVENUE BY TYPE (2013-2018) (MILLION USD) 59
TABLE 43 GLOBAL CRISPR Cas Genes Market REVENUE SHARE BY TYPE (2013-2018) 59
TABLE 44 CRISPR Cas Genes Market PRICE BY SMART LENSES013-2018 (USD/UNIT) 61
TABLE 45 GLOBAL CRISPR Cas Genes Market CONSUMPTION BY APPLICATION (2013-2025) (MILLION UNITS) 62
TABLE 46 GLOBAL CRISPR Cas Genes Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 62
TABLE 47 GLOBAL CRISPR Cas Genes Market CONSUMPTION SHARE BY APPLICATION (2013-2018) 63
TABLE 48 COMPANY 1 COMPANY DETAILS 64
TABLE 49 COMPANY 1 DESCRIPTION AND BUSINESS OVERVIEW 64
TABLE 50 COMPANY 1 CRISPR Cas Genes Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 65
TABLE 52 COMPANY 1 CRISPR Cas Genes Market PRODUCT 65
TABLE 53 COMPANY 2 RECENT DEVELOPMENT 65
TABLE 54 COMPANY 2 COMPANY DETAILS 66
TABLE 55 COMPANY 3 DESCRIPTION AND BUSINESS OVERVIEW 66
TABLE 56 COMPANY 3 CRISPR Cas Genes Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 67
TABLE 57 COMPANY 3 CRISPR Cas Genes Market PRODUCT 67
TABLE 58 COMPANY 3 RECENT DEVELOPMENT 67
TABLE 59 COMPANY 3 COMPANY DETAILS 68
TABLE 60 COMPANY 3 DESCRIPTION AND BUSINESS OVERVIEW 68
TABLE 61 COMPANY 3 CRISPR Cas Genes Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 69
TABLE 62 COMPANY 3 CRISPR Cas Genes Market PRODUCT 69
TABLE 63 COMPANY 3 RECENT DEVELOPMENT 70
TABLE 64 COMPANY 4 COMPANY DETAILS 71
TABLE 65 COMPANY 4 DESCRIPTION AND BUSINESS OVERVIEW 71
TABLE 66 CRISPR Cas Genes Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 72
TABLE 67 COMPANY 4 CRISPR Cas Genes Market PRODUCT 72
TABLE 68 COMPANY 4 RECENT DEVELOPMENT 73
TABLE 69 COMPANY 5 OPTICAL COMPANY DETAILS 73
TABLE 70 COMPANY 5 DESCRIPTION AND BUSINESS OVERVIEW 74
TABLE 71 COMPANY5 CRISPR Cas Genes Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 74
TABLE 72 COMPANY 5 OPTICAL CRISPR Cas Genes Market PRODUCT 74
TABLE 73 COMPANY 5 OPTICAL RECENT DEVELOPMENT 74
TABLE 74 COMPANY 6 COMPANY DETAILS 75
TABLE 75 COMPANY 6 DESCRIPTION AND BUSINESS OVERVIEW 75
TABLE 76 COMPANY 6 CRISPR Cas Genes Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 76
TABLE 77 COMPANY 6 CRISPR Cas Genes Market PRODUCT 76
TABLE 78 COMPANY 7 GLOBAL COMPANY DETAILS 77
TABLE 79 COMPANY 7 DESCRIPTION AND BUSINESS OVERVIEW 77
TABLE 80 COMPANY 7 GLOBAL CRISPR Cas Genes Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 77
TABLE 81 COMPANY 7 GLOBAL CRISPR Cas Genes Market PRODUCT 78
TABLE 82 COMPANY 8 VISION COMPANY DETAILS 79
TABLE 83 COMPANY 8 DESCRIPTION AND BUSINESS OVERVIEW 79
TABLE 84 COMPANY 8 CRISPR Cas Genes Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 80
TABLE 85 COMPANY 8 CRISPR Cas Genes Market PRODUCT 80
TABLE 86 COMPANY 9 COMPANY DETAILS 81
TABLE 87 COMPANY 9 DESCRIPTION AND BUSINESS OVERVIEW 81
TABLE 88 COMPANY 9 CRISPR Cas Genes Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 81
TABLE 89 COMPANY 9 CRISPR Cas Genes Market PRODUCT 82
TABLE 90 COMPANY 10 COMPANY DETAILS 83
TABLE 91 COMPANY 10 DESCRIPTION AND BUSINESS OVERVIEW 83
TABLE 92 COMPANY 10 CRISPR Cas Genes Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 83
TABLE 93 COMPANY 10 CRISPR Cas Genes Market PRODUCT 84
TABLE 94 GLOBAL CRISPR Cas Genes Market REVENUE FORECAST BY REGIONS 2018-2025 (MILLION USD) 86
TABLE 95 GLOBAL CRISPR Cas Genes Market PRODUCTION FORECAST BY REGIONS 2018-2025 (MILLION UNITS) 87
TABLE 96 GLOBAL CRISPR Cas Genes Market PRODUCTION FORECAST BY TYPE (2018-2025) (MILLION UNITS) 94
TABLE 97 CRISPR Cas Genes Market REVENUE FORECAST BY TYPE (2018-2025) (MILLION USD) 95
TABLE 98 GLOBAL CRISPR Cas Genes Market CONSUMPTION FORECAST BY APPLICATION (2018-2025) (MILLION UNITS) 96
TABLE 99 GLOBAL CRISPR Cas Genes Market CONSUMPTION FORECAST BY REGIONS 2018-2025 (MILLION UNITS) 97
TABLE 100 CRISPR Cas Genes Market DISTRIBUTORS LIST 103
TABLE 101 KEY OPPORTUNITIES AND DRIVERS 104
TABLE 102 KEY CHALLENGES 104
TABLE 103 MARKET RISKS 104
TABLE 104 RESEARCH PROGRAMS/DESIGN FOR THIS REPORT 108
TABLE 105 KEY DATA INFORMATION FROM SECONDARY SOURCES 112
TABLE 106 KEY DATA INFORMATION FROM PRIMARY SOURCES 113
